EP 1030660 B1 20040310 - A TRANSDERMAL DRUG DELIVERY SYSTEM FOR ANTI-INFLAMMATORY ANALGESIC AGENT COMPRISING DICLOFENAC DIETHYLAMMONIUM SALT, AND THE MANUFACTURING METHOD THEREOF
Title (en)
A TRANSDERMAL DRUG DELIVERY SYSTEM FOR ANTI-INFLAMMATORY ANALGESIC AGENT COMPRISING DICLOFENAC DIETHYLAMMONIUM SALT, AND THE MANUFACTURING METHOD THEREOF
Title (de)
TRANSDERMALES ARZNEISTOFF-ABGABESYSTEM FÜR EIN ENTZÜNDUNGSHEMMENDES ANALGETISCHES MITTEL ENTHALTEND DICLOFENAC DIETHYLAMMONIUM SALZ, UND VERFAHREN ZU DESSEN HERSTELLUNG
Title (fr)
SYSTEME D'ADMINISTRATION TRANSDERMIQUE DE MEDICAMENT POUR AGENT ANALGESIQUE ET ANTI-INFLAMMATOIRE COMPORTANT DU SEL DE DICLOFENAC-DIETHYLAMMONIUM ET PROCEDE DE FABRICATION CORRESPONDANT
Publication
Application
Priority
- KR 9800295 W 19980925
- KR 19970049084 A 19970926
Abstract (en)
[origin: WO9916434A1] The invention herein relates to a transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, wherein a backing film (1), a matrix layer (2) containing active ingredients, a release liner (3) which is removed before application onto the skin are laminated therein. More particularly, the invention herein relates to a transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, wherein the transdermal penetration and adhesion of the patch to the body are enhanced by means of a matrix layer which comprises a diclofenac diethylammonium salt as active ingredient in addition to acrylic polymer as adhesive constituent, non-ionic surfacant as absorption enhancer, terpene and dissolution assistant, and the volatile and non-volatile constituents of the composition are separately applied therein for significantly reducing the manufacturing time thereof.
IPC 1-7
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/195 (2006.01); A61K 31/196 (2006.01); A61K 47/10 (2006.01); A61K 47/14 (2006.01); A61K 47/18 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP KR US)
A61K 9/70 (2013.01 - KR); A61K 9/703 (2013.01 - EP US); A61K 9/7061 (2013.01 - EP US); A61K 31/196 (2013.01 - EP US); A61P 29/00 (2017.12 - EP)
Designated contracting state (EPC)
CH DE ES FR GB IT LI NL SE
DOCDB simple family (publication)
WO 9916434 A1 19990408; AU 726448 B2 20001109; AU 9464798 A 19990423; BR 9815378 A 20001121; BR 9815378 B1 20100518; CA 2304784 A1 19990408; CA 2304784 C 20030422; CN 1180773 C 20041222; CN 1271280 A 20001025; DE 69822327 D1 20040415; DE 69822327 T2 20050317; EP 1030660 A1 20000830; EP 1030660 B1 20040310; ES 2213916 T3 20040901; HK 1030161 A1 20010427; JP 2001517696 A 20011009; KR 100305216 B1 20011130; KR 19990026792 A 19990415; KR 19990029556 A 19990426; NZ 503112 A 20020201; US 6723337 B1 20040420
DOCDB simple family (application)
KR 9800295 W 19980925; AU 9464798 A 19980925; BR 9815378 A 19980925; CA 2304784 A 19980925; CN 98809473 A 19980925; DE 69822327 T 19980925; EP 98947969 A 19980925; ES 98947969 T 19980925; HK 01101243 A 20010221; JP 2000513570 A 19980925; KR 19970049084 A 19970926; KR 19980036559 A 19980904; NZ 50311298 A 19980925; US 50930300 A 20000619